Related Experiment Video
Updated: May 19, 2026

Transfection of a Molecular Clone of Naegleria gruberi rDNA into N. gruberi Trophozoites
Published on: June 21, 2024
Primary Amoebic Meningoencephalitis in an Infant due to Naegleria fowleri
Vinay Khanna1, Ruchee Khanna, Shrikiran Hebbar
1Department of Microbiology, Kasturba Medical College, Manipal, 576104 Karnataka, India.
Abstract:
Primary amoebic meningoencephalitis (PAM) caused by free-living amebae Naegleria fowleri is a rare and fatal condition. A fatal case of primary amoebic meningoencephalitis was diagnosed in a 5-month-old infant who presented with the history of decrease breast feeding, fever, vomiting, and abnormal body movements. Trophozoites of Naegleria fowleri were detected in the direct microscopic examination of CSF and infant was put on amphotericin B and ceftazidime. Patient condition deteriorated, and he was discharged against medical advice and subsequently expired. We also reviewed previously reported 8 Indian cases of primary amoebic meningoencephalitis (PAM) and observed that for the last 5 years, none of the patients responded to amphotericin B. Has an era of amphotericin B-resistant Naegleria fowleri been emerged? Management strategy of PAM needs to be reviewed further.
Insights
Primary amoebic meningoencephalitis (PAM), a rare and fatal infection caused by Naegleria fowleri, is increasingly resistant to amphotericin B. This case highlights the urgent need to re-evaluate treatment strategies for this devastating amebic brain infection.
Area of Science:
- Neurology
- Infectious Diseases
- Microbiology
Background:
- Primary amoebic meningoencephalitis (PAM) is a rare, fatal infection caused by the free-living amoeba Naegleria fowleri.
- Early diagnosis and treatment are critical for patient survival.
Observation:
- A 5-month-old infant presented with symptoms including decreased feeding, fever, vomiting, and abnormal movements.
- Naegleria fowleri trophozoites were identified in cerebrospinal fluid (CSF).
- Despite treatment with amphotericin B and ceftazidime, the infant's condition worsened, leading to expiration.
Findings:
- Review of 8 previous Indian cases revealed no patient response to amphotericin B in the last 5 years.
- This suggests a potential emergence of amphotericin B-resistant Naegleria fowleri strains.
Implications:
- The findings challenge the efficacy of current treatment protocols for PAM.
- There is a critical need for revised management strategies and development of novel therapeutic agents against Naegleria fowleri.
- Further research is essential to understand the mechanisms of amphotericin B resistance in Naegleria fowleri.
Related Concept Videos
Encephalitis l: Introduction
Bacterial Meningitis I: Introduction
Bacterial Meningitis II: Pathophysiology
Viral Meningitis
Encephalitis ll: Pathophysiology
Arboviral Encephalitis
